MAO-B inhibitor, used in Parkinson's disease to slow down the destruction of dopamine.
Acetylcholinesterase inhibitor, improves cognitive function in Alzheimer's disease and dementia.
Alzheimer's disease and Parkinson's disease are neurodegenerative disorders that significantly affect patients' quality of life by causing cognitive and motor impairment. Our mission is to provide information about modern medications that help slow the progression of these diseases and alleviate their symptoms.
The drug helps support cognitive function in Alzheimer's disease by improving memory and orientation. It is available in capsules, solution and patches for convenient use in everyday life.
The drug acts on neurotransmitters, increasing their levels in the brain, which helps improve memory, attention and ability to perform everyday tasks. Formats of release allow you to choose the most suitable option: capsules and solution are suitable for oral administration, and transdermal systems provide a stable supply of the active substance overnight. This is especially important for patients who have difficulty taking medication regularly. The product is effective in early and moderate stages of the disease, helping to slow the loss of cognitive skills and maintain the patient's independence.
The capsules are designed to treat Parkinson's disease by helping to reduce tremors and improve motor function. They are taken orally and can be used alone or with other medications.
The drug works by increasing dopamine levels in the brain, which helps reduce the severity of symptoms such as rigidity, slowness of movement and tremor. It can be used in the early stages as a single remedy or in combination with other drugs at later stages to enhance the effect. The tablets are easy to use, and their dosage allows flexible adjustment of treatment depending on the needs of the patient. The drug also has potential neuroprotective properties, which may slow down degenerative processes in neurons.
The choice of drug depends on the diagnosis, stage of disease and individual characteristics of the patient. Exelon is suitable for those who face cognitive impairment in Alzheimer's disease, while Eldepryl will be the optimal solution for patients with movement disorders caused by Parkinson's disease. It is important to consider comorbidities, age and tolerance to the medication. We recommend that you read the instructions for each medication to understand its features, indications and possible side effects.
On our website you can read detailed information about each drug, including composition, methods of use and dosage recommendations. We work with trusted pharmacies and distributors to ensure that medications are available to everyone who needs them. For more information or advice, please contact us via our contact form or at the contacts listed.